title: Progress and pitfalls in Shigella vaccine research.
abstract: Renewed awareness of the substantial morbidity and mortality that Shigella infection causes among young children in developing countries, combined with technological innovations in vaccinology, has led to the development of novel vaccine strategies in the past 5 years. Along with advancement of classic vaccines in clinical trials and new sophisticated measurements of immunological responses, much new data has been produced, lending promise to the potential for production of safe and effective Shigella vaccines. Herein, we review the latest progress in Shigella vaccine development within the framework of persistent obstacles.
authors: University of Maryland School of Medicine, Center for Vaccine Development, Baltimore, MD 21201, USA.
authors: Eileen M
authors: EM
authors: Barry
authors: Marcela F
authors: MF
authors: Pasetti
authors: Marcelo B
authors: MB
authors: Sztein
authors: Alessio
authors: A
authors: Fasano
authors: Karen L
authors: KL
authors: Kotloff
authors: Myron M
authors: MM
authors: Levine
mesh_terms: D035843:Biomedical Research / Q000191:economics; D002986:Clinical Trials as Topic / Q000191:economics; D003906:Developing Countries; D004405:Dysentery, Bacillary / Q000276:immunology* / Q000517:prevention & control*; D006801:Humans; D012109:Research Support as Topic; D012760:Shigella / Q000276:immunology / Q000472:pathogenicity; D022281:Shigella Vaccines / Q000276:immunology*
chemical_list: D022281:Shigella Vaccines